Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
61 studies found for:    Open Studies | "Cytomegalovirus Infections"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis
Conditions: Ulcerative Colitis;   Cytomegalovirus Infections
Intervention:
2 Recruiting Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence
Condition: Cytomegalovirus Infections
Interventions: Drug: Drug conversion to sirolimus;   Drug: Maintenance of the current regimen
3 Unknown  Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection
Conditions: Disorder of Transplanted Kidney;   Cytomegalovirus Infections
Intervention:
4 Recruiting Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporineversus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A
Conditions: Transplantation Infection;   Cytomegalovirus Infection
Interventions: Drug: Everolimus;   Drug: mycophenolic acid
5 Recruiting Evaluation of the PK and PD of Ganciclovir in Premature Infants Receiving Treatment for CMV Infection
Condition: Cytomegalovirus Infections
Intervention:
6 Recruiting Analysis of CMV Infections in Patients With Brain Tumors or Brain Metastases During and After Radio(Chemo)Therapy
Condition: Cytomegalovirus Infections
Intervention: Other: Blood draw and MRI
7 Recruiting Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening
Condition: Congenital Cytomegalovirus Infection
Intervention: Other: CMV PCR
8 Recruiting MSC for Treatment of CMV Infection
Conditions: Stem Cell Transplantation, Hematopoietic;   CMV Infection;   Hematological Diseases
Intervention: Biological: MSCs
9 Recruiting A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China
Condition: Congenital Cytomegalovirus Infection
Intervention:
10 Not yet recruiting Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation
Conditions: Cytomegalovirus Infection;   Adenovirus Infection
Intervention: Biological: virus-specific T-Cells
11 Recruiting Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV
Condition: Congenital Cytomegalovirus Infection
Intervention: Other: olfactory tests, otoacoustic emissions (OAE)
12 Recruiting A Cohort Study of Cytomegalovirus(CMV) Infection Among Pregnant Women and Their Newborns in China
Conditions: Congenital Cytomegalovirus Infection;   Cytomegalovirus Infection Reactivation
Intervention:
13 Unknown  Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients
Condition: Cytomegalovirus Disease
Interventions: Drug: Certican (everolimus) + valganciclovir;   Drug: Valganciclovir
14 Recruiting A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Conditions: Congenital Cytomegalovirus Infection;   Maternal Cytomegalovirus Infection
Intervention: Drug: CMV hyperimmune globulin
15 Recruiting Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: CMV Infection;   Persistent CMV Viremia
Intervention: Genetic: CMVpp65 Specific T-cells
16 Recruiting Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy
Conditions: Pregnancy;   Cytomegalovirus Infections;   Congenital Infection
Intervention:
17 Recruiting Cell-mediated Immunity for Prevention of CMV Disease
Condition: Cytomegalovirus Infections
Intervention: Other: T-Track® CMV assay
18 Unknown  Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy
Conditions: Heart Transplantation;   Cardiac Allograft Vasculopathy;   Cytomegalovirus Infection
Interventions: Drug: Pre-emptive strategy with valganciclovir plus everolimus;   Drug: Prophylaxis with valganciclovir plus mycophenolate;   Drug: Prophylaxis with valganciclovir plus everolimus;   Drug: Pre-emptive mycophenolate
19 Unknown  Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients
Condition: Cytomegalovirus Infections
Interventions: Drug: Everolimus+Tacrolimus+Prednisone;   Drug: Mycophenolate+Tacrolimus+Prednisone
20 Recruiting Study to Evaluate Safety, Tolerability, and Immunogenicity of Candidate Human Cytomegalovirus Vaccine in Healthy Adults
Condition: Cytomegalovirus Infections
Interventions: Drug: VBI-1501A;   Drug: VBI-1501;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years